Princeton Portfolio Strategies Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,752
Closed -$212K 152
2018
Q4
$212K Hold
2,752
0.07% 138
2018
Q3
$212K Sell
2,752
-580
-17% -$42.9K 0.06% 149
2018
Q2
$226K Hold
3,332
0.07% 142
2018
Q1
$241K Sell
3,332
-224
-6% -$17.1K 0.07% 140
2017
Q4
$267K Sell
3,556
-445
-11% -$33.6K 0.07% 139
2017
Q3
$308K Sell
4,001
-279
-7% -$21.1K 0.08% 148
2017
Q2
$320K Sell
4,280
-413
-9% -$29.3K 0.09% 139
2017
Q1
$312K Hold
4,693
0.09% 143
2016
Q4
$306K Sell
4,693
-1,088
-19% -$70.6K 0.1% 128
2016
Q3
$409K Sell
5,781
-7,883
-58% -$574K 0.13% 114
2016
Q2
$1.01M Sell
13,664
-7,730
-36% -$534K 0.33% 76
2016
Q1
$1.39M Sell
21,394
-268
-1% -$18.2K 0.47% 63
2015
Q4
$1.67M Buy
21,662
+124
+0.6% +$9.85K 0.59% 55
2015
Q3
$1.77M Buy
21,538
+473
+2% +$42.1K 0.72% 52
2015
Q2
$1.86M Buy
21,065
+224
+1% +$20.5K 0.65% 58
2015
Q1
$1.84M Sell
20,841
-1,635
-7% -$145K 0.71% 54
2014
Q4
$1.87M Sell
22,476
-419
-2% -$34.7K 0.74% 53
2014
Q3
$1.93M Buy
22,895
+3,136
+16% +$254K 0.81% 49
2014
Q2
$1.6M Buy
19,759
+826
+4% +$65K 0.69% 58
2014
Q1
$1.44M Buy
18,933
+1,306
+7% +$95.2K 0.95% 40
2013
Q4
$1.27M Sell
17,627
-4,029
-19% -$280K 0.85% 42
2013
Q3
$1.49M Sell
21,656
-1,228
-5% -$81.2K 1.1% 29
2013
Q2
$1.45M Buy
+22,884
New +$1.49M 1.19% 26

Other funds holding NVS

Princeton Portfolio Strategies Group's NVS Position: Q1 2019 in Review

Princeton Portfolio Strategies Group sold out of Novartis (NVS) in Q1 2019, closing a stake of 2,752 shares — an estimated $212K sold.

Princeton Portfolio Strategies Group first reported a position in NVS in Q2 2013 and held it in 23 quarters. The position peaked at $1.93M in Q3 2014. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

  • Princeton Portfolio Strategies Group reported no remaining Novartis position as of Q1 2019 after selling out during the quarter.
  • Princeton Portfolio Strategies Group sold 2,752 Novartis shares in Q1 2019, an estimated $212K.
  • Princeton Portfolio Strategies Group first reported a position in Novartis in Q2 2013 and held it in 23 quarters.
  • Princeton Portfolio Strategies Group's Novartis position peaked at $1.93M in Q3 2014.
  • 1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on Princeton Portfolio Strategies Group's 13F filing for Q1 2019, filed 10 May 2019.